首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   178篇
  免费   1篇
化学工业   60篇
金属工艺   11篇
机械仪表   3篇
建筑科学   5篇
矿业工程   3篇
轻工业   2篇
水利工程   14篇
石油天然气   16篇
无线电   10篇
一般工业技术   14篇
冶金工业   18篇
原子能技术   18篇
自动化技术   5篇
  2022年   20篇
  2021年   12篇
  2019年   3篇
  2018年   3篇
  2017年   7篇
  2016年   8篇
  2014年   6篇
  2013年   5篇
  2012年   3篇
  2011年   2篇
  2010年   2篇
  2009年   3篇
  2007年   2篇
  2006年   2篇
  2005年   4篇
  2003年   6篇
  2002年   3篇
  1998年   2篇
  1997年   7篇
  1996年   2篇
  1995年   3篇
  1992年   2篇
  1991年   1篇
  1990年   1篇
  1989年   3篇
  1988年   1篇
  1987年   1篇
  1986年   1篇
  1985年   1篇
  1984年   1篇
  1983年   2篇
  1982年   4篇
  1981年   2篇
  1980年   2篇
  1979年   2篇
  1978年   5篇
  1977年   3篇
  1976年   8篇
  1975年   5篇
  1974年   3篇
  1973年   2篇
  1971年   1篇
  1970年   1篇
  1969年   4篇
  1967年   4篇
  1966年   4篇
  1965年   3篇
  1964年   1篇
  1959年   1篇
  1958年   1篇
排序方式: 共有179条查询结果,搜索用时 0 毫秒
171.
172.
173.
174.
The subfraction of low density lipoprotein (LDL) with low sialic acid content that caused accumulation of cholesterol esters in human aortic smooth muscle cells has been found in the blood of coronary atherosclerosis patients. It was demonstrated that this subfraction consists of LDL with small size, high electronegative charge, reduced lipid content, altered tertiary structure of apolipoprotein B, etc. LDL of this subfraction is naturally occurring multiple-modified LDL (nomLDL). In this study we compared the binding, uptake and proteolytic degradation of native LDL and nomLDL by smooth muscle cells cultured from human grossly normal intima, fatty streaks, and atherosclerotic plaques. Uptake of nomLDL by normal and atherosclerotic cells was 3.5- and 6-fold, respectively, higher than uptake of native LDL. Increased uptake of nomLDL was due to increased binding of this LDL by intimal smooth muscle cells. The enhanced binding is explained by the interaction of nomLDL with cellular receptors other than LDL-receptor. Modified LDL interacted with the scavenger receptor, asialoglycoprotein receptor, and also with cell surface proteoglycans. Rates of degradation of nomLDL were 1.5- and 5-fold lower than degradation of native LDL by normal and atherosclerotic cells, respectively. A low rate of nomLDL degradation was also demonstrated in homogenates of intimal cells. Activities of lysosomal proteinases of atherosclerotic cells were decreased compared with normal cells. Pepstatin A, a cathepsin D inhibitor, completely inhibited lipoprotein degradation, while serine, thiol, or metallo-proteinase inhibitors had partial effect. This fact reveals that cathepsin D is involved in initial stages of apoB degradation by intimal smooth muscle cells. Obtained data show that increased uptake and decreased lysosomal degradation of nomLDL may be the main cause of LDL accumulation in human aortic smooth muscle cells, leading to foam cell formation.  相似文献   
175.
176.
177.
In the present study, the mechanism of the in vitro effect of garlic powder extract (GPE) on lipid content of cultured human aortic cells was investigated. The addition of GPE abolished atherogenic blood serum-induced accumulation of free cholesterol, triglycerides, and cholesteryl esters in smooth muscle cells derived from uninvolved (normal) intima. In cells isolated from atherosclerotic plaque, GPE lowered these lipids. GPE inhibited lipid synthesis both in normal and atherosclerotic cells. It inhibited acyl-CoA:cholesterol acyltransferase activity that participates in the cholesteryl ester formation and stimulated cholesteryl ester hydrolase that degrades cholesteryl esters. This may explain the lipid reduction caused by GPE in atherosclerotic cells. GPE inhibited the uptake of modified low density lipoprotein and degradation of lipoprotein-derived cholesteryl esters, thus considerably reducing the intracellular accumulation of cholesteryl esters. This suggests the mechanism responsible for the prevention of lipid accumulation in aortic cells caused by atherogenic blood serum.  相似文献   
178.
179.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号